| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0208632511155817 | 0.35617195 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0208632511155817 | 0.3805388 |
| NSC 295641 | Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester | 0.0208632511155817 | -0.016550283 |
| NSC 317908 | Null | 0.0208632511155817 | 0.17806809 |
| NSC 627778 | Null | 0.0208632511155817 | 0.03155976 |
| NSC 631306 | cis-Amminedichloro(4-methoxyphenethylamine)platinum(II) | 0.0208632511155817 | 0.45415153 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.0208632511155817 | 0.37369149 |
| NSC 641297 | ANTINEOPLASTIC-641297 | 0.0208632511155817 | 0.22637664 |
| NSC 643813 | 3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] | 0.0208632511155817 | 0.28816162 |
| NSC 646610 | Null | 0.0208632511155817 | 0.25616582 |